Synthetic vessel grafts have been used as vascular substitutes for cardiovascular bypass procedures. In this study, we developed a novel tubular double-layered poly(l-lactide-co-ϵ-caprolactone) scaffold that did not require pretreatment with cell seeding by promoting autologous tissue regeneration by inducing the proliferation and differentiation of endothelial and smooth muscle progenitor cells after implantation. The patency and mechanical properties were maintained for one year after implantation, although 95% of the poly(l-lactide-co-ϵ-caprolactone) scaffolds had degraded. After this period, there was a lining of endothelial cells, an accumulation of collagen and elastin, and the development of neovascularization inside the poly(l-lactide-co-ϵ-caprolactone).
BaguneidMde MelAYildirimerL. In vivo study of a model tissue-engineered small-diameter vascular bypass graft. Biotechnol Appl Biochem2011; 58(1): 14–24.
2.
de MelAJellGStevensMM. Biofunctionalization of biomaterials for accelerated in situ endothelialization: a review. Biomacromolecules2008; 9(11): 2969–2979.
3.
NieponiceASolettiLGuanJ. In vivo assessment of a tissue-engineered vascular graft combining a biodegradable elastomeric scaffold and muscle-derived stem cells in a rat model. Tissue Eng Part A2010; 16(4): 1215–1223.
4.
De ValenceSTilleJCMugnaiD. Long term performance of polycaprolactone vascular grafts in a rat abdominal aorta replacement model. Biomaterials2011; 33(1): 38–47.
5.
ParadisGChioleroA. The cardiovascular and chronic diseases epidemic in low- and middle-income countries: a global health challenge. J Am Coll Cardiol2011; 57(17): 1775–1777.
6.
KastoriniCMMilionisHJIoannidiA. Adherence to the Mediterranean diet in relation to acute coronary syndrome or stroke nonfatal events: a comparative analysis of a case/case-control study. Am Heart J2011; 162(4): 717–724.
7.
FiorettaESFledderusJOBurakowska-MeiseEA. Polymer-based scaffold designs for in situ vascular tissue engineering: controlling recruitment and differentiation behavior of endothelial colony forming cells. Macromol Biosci2012; 12(5): 577–590.
8.
XuWWangXYanY. Rapid prototyping of polyurethane for the creation of vascular systems. J Bioact Compat Pol2008; 23: 103–114.
9.
HehrleinFSchlepperMLoskotF. The use of expanded polytetrafluoroethylene (PTFE) grafts for myocardial revascularization. J Cardiovasc Surg1984; 25(6): 549.
WhittemoreADKentKCDonaldsonMC. What is the proper role of polytetrafluoroethylene grafts in infrainguinal reconstruction?J Vasc Surg1989; 10(3): 299–305.
12.
GreislerHP. Interactions at the blood/material interface. Ann Vasc Surg1990; 4(1): 98–103.
13.
ChoSWLimJEChuHS. Enhancement of in vivo endothelialization of tissue-engineered vascular grafts by granulocyte colony-stimulating factor. J Biomed Mater Res A2006; 76(2): 252–263.
14.
SarkarSSalesKMHamiltonG. Addressing thrombogenicity in vascular graft construction. J Biomed Mater Res B Appl Biomater2007; 82(1): 100–108.
15.
MarascoCC. A theoretical approach to synthetic vascular graft design: surface micro-topography optimization for promoting the retention of endothelial cells. MSc Thesis, Vanderbilt University, Nashville, TN, 2007.
16.
RashidSSalacinskiHFullerB. Engineering of bypass conduits to improve patency. Cell Prolif2004; 37(5): 351–366.
17.
RaviSQuZChaikofEL. Polymeric materials for tissue engineering of arterial substitutes. Vascular2009; 17(Suppl. 1): S45–S54.
18.
SonodaHTakamizawaKNakayamaY. Coaxial double-tubular compliant arterial graft prosthesis: time-dependent morphogenesis and compliance changes after implantation. J Biomed Mater Res A2003; 65(2): 170–181.
19.
HassanKKimSHParkI. Small diameter double layer tubular scaffolds using highly elastic PLCL copolymer for vascular tissue engineering. Macromol Res2011; 19(2): 122–129.
20.
FreedLMarquisJNohriaA. Neocartilage formation in vitro and in vivo using cells cultured on synthetic biodegradable polymers. J Biomed Mater Res1993; 27(1): 11–23.
21.
DameMKYuXGarridoR. A stepwise method for the isolation of endothelial cells and smooth muscle cells from individual canine coronary arteries. In Vitro Cell Dev Biol Anim2003; 39(10): 402–406.
22.
WilliamsonMRCoombesAGA. Gravity spinning of polycaprolactone fibres for applications in tissue engineering. Biomaterials2004; 25(3): 459–465.
23.
ZhangH. Electrospun poly(lactic-co-glycolic acid)/multiwalled carbon nanotubes composite scaffolds for guided bone tissue regeneration. J Bioact Compat Pol2011; 26: 347–362.
24.
KimSHChungEJungY. A novel seamless elastic scaffold for vascular tissue engineering. J Biomater Sci Polym Ed2010; 21(3): 289–302.
25.
KyriakidouKLucariniGZizziA. Dynamic co-seeding of osteoblast and endothelial cells on 3D polycaprolactone scaffolds for enhanced bone tissue engineering. J Bioact Compat Pol2008; 23: 227–243.
26.
LiS. Nonthrombogenic approaches to cardiovascular tissue engineering. Annu Rev Biomed Eng2011; 13(1): 451–475.
27.
KimSHKwonJHChungMS. Fabrication of a new tubular fibrous PLCL scaffold for vascular tissue engineering. J Biomater Sci Polym Ed2006; 17(12): 1359–1374.
28.
CrapoPMWangY. Physiologic compliance in engineered small-diameter arterial constructs based on an elastomeric substrate. Biomaterials2010; 31(7): 1626–1635.
29.
StitzelJLiuJLeeSJ. Controlled fabrication of a biological vascular substitute. Biomaterials2006; 27(7): 1088–1094.
30.
YokotaTIchikawaHMatsumiyaG. In situ tissue regeneration using a novel tissue-engineered, small-caliber vascular graft without cell seeding. J Thorac Cardiovasc Surg2008; 136(4): 900–907.
31.
FahnerPJLegemateDAVan der WalAC. Comparison of preserved vascular allografts using glycerol and University of Wisconsin solution in a goat carotid artery transplantation model. Eur Surg Res2011; 48(2): 64–72.
32.
RaviSChaikofEL. Biomaterials for vascular tissue engineering. Regen Med2010; 5(1): 107–120.
33.
WangXSuiSYanY. Design and fabrication of PLGA sandwiched cell/fibrin constructs for complex organ regeneration. J Bioact Compat Pol2010; 25(3): 229–240.
34.
YanYWangXHYinD. A new polyurethane/heparin vascular graft for small-caliber vein repair. J Bioact Compat Pol2007; 22(3): 323–341.
35.
HuXLiuGJiJ. Lipid-like diblock copolymer as an additive for improving the blood compatibility of poly (lactide-co-glycolide). J Bioact Compat Pol2010; 25(6): 654–668.
36.
PandisLZavanBAbatangeloG. Hyaluronan-based scaffold for in vivo regeneration of the rat vena cava: preliminary results in an animal model. J Biomed Mater Res A2010; 93(4): 1289–1296.
37.
TosunZVillegas-MontoyaCMcFetridgePS. The influence of early-phase remodeling events on the biomechanical properties of engineered vascular tissues. J Vasc Surg2011; 54(5): 1451–1460.
38.
MalmCJRisbergBBodinA. Small calibre biosynthetic bacterial cellulose blood vessels: 13-months patency in a sheep model. Scand Cardiovasc J2012; 46(1): 57–62.
39.
YazdaniSKTillmanBWBerryJL. The fate of an endothelium layer after preconditioning. J Vasc Surg2010; 51(1): 174–183.
40.
Avci-AdaliMZiemerGWendelHP. Induction of EPC homing on biofunctionalized vascular grafts for rapid in vivo self-endothelialization—a review of current strategies. Biotechnol Adv2010; 28(1): 119–129.
41.
BrennanMPDardikAHibinoN. Tissue engineered vascular grafts demonstrate evidence of growth and development when implanted in a juvenile animal model. Ann Surg2008; 248(3): 370.
42.
De VisscherGMesureLMeurisB. Improved endothelialization and reduced thrombosis by coating a synthetic vascular graft with fibronectin and stem cell homing factor SDF-1α. Acta Biomater2011; 8(3): 1330–1338.
43.
WissinkMBeerninkRPootA. Improved endothelialization of vascular grafts by local release of growth factor from heparinized collagen matrices. J Control Release2000; 64(1): 103–114.
44.
KumarTSKrishnanLK. A stable matrix for generation of tissue-engineered nonthrombogenic vascular grafts. Tissue Eng2002; 8(5): 763–770.
45.
ShiQBhattacharyaVHong-De WuM. Utilizing granulocyte colony—stimulating factor to enhance vascular graft endothelialization from circulating blood cells. Ann Vasc Surg2002; 16(3): 314–320.
46.
RotmansJIHeyligersJMMVerhagenHJM. In vivo cell seeding with anti-CD34 antibodies successfully accelerates endothelialization but stimulates intimal hyperplasia in porcine arteriovenous expanded polytetrafluoroethylene grafts. Circulation2005; 112(1): 12–18.
47.
Murray-WijelathJLymanDJWijelathES. Vascular graft healing. III. FTIR analysis of PTFE graft samples from implanted bigrafts. J Biomed Mater Res B Appl Biomater2004; 70(2): 223–232.
